Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating multiple-dose safety, pharmacokinetics, and pharmacodynamics of COR-001 in anemia, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• COR-001

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Anemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-30